Sermes CRO provides global coverage, nationally with offices based in Madrid and Barcelona and internationally through our integration into PSN. In response to customers’ needs, we have a highly qualified staff structure that allows us to guarantee flexibility and adaptation to the needs, solving both specific services and integrated projects.
This experience and career has certainly based on the company flexibility to legislative and process changes. This allows our organization to adapt both the processes and the team, to the clinical trial requirements in order to ensure the customer or developer maximum satisfaction.
Such corporate flexibility is certainly aligned to the customer proximity shown by the company, from independent research to international pharmaceutical companies. Sermes CRO has a long history of collaboration with local and international independent research and certainly has an excellent image outside Spain.
Aligned with the flexibility and customer proximity , Sermes CRO is based on a highly skilled human capital which is constantly improving, along with the integration of disabled persons in all the organization aspects, this point is aligned with the social value of the company and adds value to any customer towards the current legislation compliance.
Please visit on the following link the members of our team
Aligned with the flexibility and customer proximity , Sermes CRO is based on a highly skilled human capital which is constantly improving, along with the integration of disabled persons in all the organization aspects, this point is aligned with the social value of the company and adds value to any customer towards the current legislation compliance.
The Essential Role of CROs in Clinical Research
Sermes CRO
ICH E9 and CDISC: The Master Formula for Excellence in Clinical Research and Data Management
Sermes CRO
Transforming Clinical Research through Artificial Intelligence
Sermes CRO
Analysis of Express Import Authorizations for medical devices
Sermes CRO
Clinical trials: the patient's perspective
Sermes CRO
Nominal variables are more than just a name
Sermes CRO
AEDESEO y Sermes CRO, colaborando para visibilizar la Esofagitis Eosinofílica
Sermes CRO
'Advanced Therapies are the medicine of the future': Mercedes Zurita, researcher and head of the Cell Therapy Unit at Puerta de Hierro Hospital
Sermes CRO
Esofagitis Eosinofílica: entrevistamos a la presidenta de AEDESEO, Miriam Espinosa
Sermes CRO
Sermes CRO: Novedades sobre el nuevo portal europeo de ensayos clínicos de la EMA (CTIs)
Sermes CRO
